{"id":85188,"date":"2021-03-25T02:48:35","date_gmt":"2021-03-25T05:48:35","guid":{"rendered":"https:\/\/iclos.global\/eng\/?page_id=85188"},"modified":"2021-06-03T03:13:27","modified_gmt":"2021-06-03T06:13:27","slug":"business-model","status":"publish","type":"page","link":"https:\/\/iclos.global\/eng\/business-model\/","title":{"rendered":"Business Model"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row unlock_row_content=\u00bbyes\u00bb row_height_percent=\u00bb1&#8243; override_padding=\u00bbyes\u00bb h_padding=\u00bb0&#8243; top_padding=\u00bb0&#8243; bottom_padding=\u00bb0&#8243; back_color=\u00bbcolor-877404&#8243; back_image=\u00bb84490&#8243; back_repeat=\u00bbrepeat-y\u00bb back_position=\u00bbcenter center\u00bb overlay_alpha=\u00bb50&#8243; equal_height=\u00bbyes\u00bb gutter_size=\u00bb0&#8243; column_width_percent=\u00bb0&#8243; shift_y=\u00bb0&#8243; z_index=\u00bb0&#8243; medium_visibility=\u00bbyes\u00bb mobile_visibility=\u00bbyes\u00bb css=\u00bb.vc_custom_1616373523038{margin-top: 0px !important;margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}\u00bb back_size=\u00bb100%\u00bb][vc_column column_width_percent=\u00bb100&#8243; position_vertical=\u00bbmiddle\u00bb align_horizontal=\u00bbalign_center\u00bb gutter_size=\u00bb3&#8243; style=\u00bbdark\u00bb overlay_alpha=\u00bb50&#8243; shift_x=\u00bb0&#8243; shift_y=\u00bb0&#8243; shift_y_down=\u00bb0&#8243; z_index=\u00bb0&#8243; medium_width=\u00bb0&#8243; mobile_width=\u00bb0&#8243; width=\u00bb1\/1&#8243;][\/vc_column][\/vc_row][vc_row unlock_row_content=\u00bbyes\u00bb row_height_percent=\u00bb50&#8243; override_padding=\u00bbyes\u00bb h_padding=\u00bb0&#8243; top_padding=\u00bb0&#8243; bottom_padding=\u00bb0&#8243; overlay_alpha=\u00bb50&#8243; equal_height=\u00bbyes\u00bb gutter_size=\u00bb0&#8243; column_width_percent=\u00bb100&#8243; shift_y=\u00bb0&#8243; z_index=\u00bb0&#8243; el_class=\u00bbdestructor-total mg-iclos\u00bb][vc_column column_width_percent=\u00bb100&#8243; gutter_size=\u00bb3&#8243; back_image=\u00bb85266&#8243; overlay_alpha=\u00bb50&#8243; shift_x=\u00bb0&#8243; shift_y=\u00bb0&#8243; shift_y_down=\u00bb0&#8243; z_index=\u00bb0&#8243; desktop_visibility=\u00bbyes\u00bb medium_width=\u00bb0&#8243; mobile_width=\u00bb0&#8243; width=\u00bb1\/3&#8243; mobile_height=\u00bb200&#8243;][\/vc_column][vc_column column_width_percent=\u00bb100&#8243; gutter_size=\u00bb0&#8243; overlay_alpha=\u00bb50&#8243; shift_x=\u00bb0&#8243; shift_y=\u00bb0&#8243; shift_y_down=\u00bb0&#8243; z_index=\u00bb0&#8243; medium_width=\u00bb0&#8243; mobile_width=\u00bb0&#8243; width=\u00bb1\/3&#8243;][vc_row_inner row_inner_height_percent=\u00bb50&#8243; overlay_alpha=\u00bb50&#8243; gutter_size=\u00bb3&#8243; shift_y=\u00bb0&#8243; z_index=\u00bb0&#8243; limit_content=\u00bb\u00bb][vc_column_inner column_width_percent=\u00bb100&#8243; gutter_size=\u00bb0&#8243; overlay_alpha=\u00bb50&#8243; shift_x=\u00bb0&#8243; shift_y=\u00bb0&#8243; shift_y_down=\u00bb0&#8243; z_index=\u00bb0&#8243; medium_width=\u00bb0&#8243; mobile_width=\u00bb0&#8243; width=\u00bb1\/1&#8243; el_class=\u00bbpg-iclos\u00bb][vc_custom_heading heading_semantic=\u00bbh3&#8243; text_font=\u00bbfont-195522&#8243; text_size=\u00bbh1&#8243; text_weight=\u00bb700&#8243; text_color=\u00bbcolor-459661&#8243; separator=\u00bbyes\u00bb separator_color=\u00bbyes\u00bb]Business Areas[\/vc_custom_heading][vc_column_text text_lead=\u00bbyes\u00bb]<\/p>\n<ul>\n<li>Development, production and marketing of chemical synthesis and biotechnological drugs, in the Latin American countries where Iclos\u2019 commercial team is present.<\/li>\n<li>Representation of pharmaceutical products from licensees in other areas. Oncology, hematology, nephrology, transplants, autoimmunity, and all therapeutic specialties involving state-of-the-art technologies, whether in chemical synthesis or biotechnological drugs.<\/li>\n<li>Development, production and marketing of active pharmaceutical ingredients of biotechnological products, for companies from any continent that are interested in the development of finished products, for marketing in territories where Iclos is not present.<\/li>\n<li>Development, production and marketing of immunosuppressants and tyrosin kinase inhibitors for countries worldwide where Iclos is not present.<\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][vc_column column_width_percent=\u00bb100&#8243; gutter_size=\u00bb3&#8243; back_image=\u00bb85266&#8243; back_position=\u00bbcenter top\u00bb overlay_alpha=\u00bb50&#8243; shift_x=\u00bb0&#8243; shift_y=\u00bb0&#8243; shift_y_down=\u00bb0&#8243; z_index=\u00bb0&#8243; medium_visibility=\u00bbyes\u00bb medium_width=\u00bb0&#8243; mobile_visibility=\u00bbyes\u00bb mobile_width=\u00bb0&#8243; width=\u00bb1\/3&#8243; el_class=\u00bbbloque-deco\u00bb back_size=\u00bb100%\u00bb][\/vc_column][\/vc_row][vc_row unlock_row_content=\u00bbyes\u00bb row_height_percent=\u00bb0&#8243; override_padding=\u00bbyes\u00bb h_padding=\u00bb0&#8243; top_padding=\u00bb0&#8243; bottom_padding=\u00bb0&#8243; overlay_alpha=\u00bb100&#8243; gutter_size=\u00bb0&#8243; style=\u00bbinherited\u00bb][\/vc_row][vc_row unlock_row_content=\u00bbyes\u00bb row_height_percent=\u00bb0&#8243; override_padding=\u00bbyes\u00bb h_padding=\u00bb0&#8243; top_padding=\u00bb0&#8243; bottom_padding=\u00bb0&#8243; overlay_alpha=\u00bb50&#8243; equal_height=\u00bbyes\u00bb gutter_size=\u00bb0&#8243; shift_y=\u00bb0&#8243;][\/vc_row][vc_row unlock_row_content=\u00bbyes\u00bb row_height_percent=\u00bb0&#8243; overlay_alpha=\u00bb50&#8243; gutter_size=\u00bb3&#8243; column_width_percent=\u00bb100&#8243; shift_y=\u00bb0&#8243; z_index=\u00bb0&#8243; el_class=\u00bbdestructor-total mg-iclos\u00bb][vc_column column_width_percent=\u00bb100&#8243; position_vertical=\u00bbbottom\u00bb gutter_size=\u00bb0&#8243; overlay_alpha=\u00bb50&#8243; shift_x=\u00bb0&#8243; shift_y=\u00bb0&#8243; shift_y_down=\u00bb0&#8243; z_index=\u00bb0&#8243; medium_width=\u00bb0&#8243; mobile_width=\u00bb0&#8243; width=\u00bb1\/2&#8243; el_class=\u00bbpg-iclos-solo-title\u00bb][vc_row_inner row_inner_height_percent=\u00bb0&#8243; overlay_alpha=\u00bb50&#8243; gutter_size=\u00bb3&#8243; shift_y=\u00bb0&#8243; z_index=\u00bb0&#8243;][vc_column_inner column_width_percent=\u00bb100&#8243; position_vertical=\u00bbbottom\u00bb gutter_size=\u00bb0&#8243; overlay_alpha=\u00bb50&#8243; shift_x=\u00bb0&#8243; shift_y=\u00bb0&#8243; shift_y_down=\u00bb0&#8243; z_index=\u00bb0&#8243; medium_width=\u00bb0&#8243; mobile_width=\u00bb0&#8243; width=\u00bb1\/1&#8243; el_class=\u00bbpg-iclos\u00bb][vc_custom_heading heading_semantic=\u00bbh3&#8243; text_font=\u00bbfont-195522&#8243; text_size=\u00bbh1&#8243; text_weight=\u00bb700&#8243; text_color=\u00bbcolor-459661&#8243; separator=\u00bbyes\u00bb separator_color=\u00bbyes\u00bb]Strategic Partners[\/vc_custom_heading][\/vc_column_inner][\/vc_row_inner][\/vc_column][vc_column width=\u00bb1\/2&#8243;][\/vc_column][\/vc_row][vc_row unlock_row_content=\u00bbyes\u00bb row_height_percent=\u00bb0&#8243; override_padding=\u00bbyes\u00bb h_padding=\u00bb7&#8243; top_padding=\u00bb2&#8243; bottom_padding=\u00bb2&#8243; overlay_alpha=\u00bb50&#8243; equal_height=\u00bbyes\u00bb gutter_size=\u00bb4&#8243; column_width_percent=\u00bb85&#8243; shift_y=\u00bb0&#8243; z_index=\u00bb0&#8243; css=\u00bb.vc_custom_1617433505145{margin-top: 0px !important;margin-bottom: 60px !important;}\u00bb el_id=\u00bbmodelo-neg-columnas\u00bb][vc_column column_width_percent=\u00bb100&#8243; gutter_size=\u00bb3&#8243; overlay_alpha=\u00bb50&#8243; shift_x=\u00bb0&#8243; shift_y=\u00bb0&#8243; shift_y_down=\u00bb0&#8243; z_index=\u00bb0&#8243; medium_width=\u00bb0&#8243; mobile_width=\u00bb0&#8243; width=\u00bb1\/4&#8243;][vc_single_image media=\u00bb86142&#8243; media_width_percent=\u00bb100&#8243;][vc_column_text text_lead=\u00bbyes\u00bb]CSL Behring is a leading global biotechnology company with a focus on rare and serious diseases. Its portfolio of innovative drugs includes a wide range of recombinant and plasma products to treat bleeding disorders, immune deficiencies and chronic inflammatory demyelinating polyneuropathy, as well as hereditary angioedema and antitrypsin alpha-1 deficiency. Iclos and CSL Behring work together in the development of blood products.[\/vc_column_text][vc_single_image media=\u00bb85274&#8243; media_width_percent=\u00bb100&#8243;][\/vc_column][vc_column width=\u00bb1\/4&#8243;][vc_single_image media=\u00bb86143&#8243; media_width_percent=\u00bb100&#8243;][vc_column_text text_lead=\u00bbyes\u00bb]Alvogen is a global pharmaceutical company focused on the development, manufacture and sale of biosimilar drugs and products for patients around the world. It is present in more than 20 markets and its key regions are the United States, Asia, and the Pacific. Iclos works together with Alvogen in the development of monoclonal antibodies for autoimmune diseases, as well as for chemical synthesis products developed for the treatment of oncological conditions of high incidence worldwide.[\/vc_column_text][vc_single_image media=\u00bb85273&#8243; media_width_percent=\u00bb100&#8243;][\/vc_column][vc_column column_width_percent=\u00bb100&#8243; gutter_size=\u00bb3&#8243; overlay_alpha=\u00bb50&#8243; shift_x=\u00bb0&#8243; shift_y=\u00bb0&#8243; shift_y_down=\u00bb0&#8243; z_index=\u00bb0&#8243; medium_width=\u00bb0&#8243; mobile_width=\u00bb0&#8243; width=\u00bb1\/4&#8243;][vc_single_image media=\u00bb86144&#8243; media_width_percent=\u00bb100&#8243;][vc_column_text text_lead=\u00bbyes\u00bb]EMS is the leader of the Brazilian pharmaceutical market with 100% Brazilian capitals. Its success is the result of constant investment in research and development, its modern manufacturing infrastructure, its speed and pioneering spirit in the launching of products, the synergy between the different business units, and its constant and growing focus on the innovation and talent of its employees.[\/vc_column_text][vc_single_image media=\u00bb86140&#8243; media_width_percent=\u00bb100&#8243;][\/vc_column][vc_column width=\u00bb1\/4&#8243;][vc_single_image media=\u00bb86145&#8243; media_width_percent=\u00bb100&#8243;][vc_column_text text_lead=\u00bbyes\u00bb]Octapharma develops and produces drugs for patients in three therapeutic areas: hematology, immunotherapy, and critical care. They are present in 31 countries, with seven R&amp;D centers and six manufacturing plants in Europe and North America.[\/vc_column_text][vc_single_image media=\u00bb86139&#8243; media_width_percent=\u00bb100&#8243;][\/vc_column][\/vc_row][vc_row unlock_row_content=\u00bbyes\u00bb row_height_percent=\u00bb50&#8243; override_padding=\u00bbyes\u00bb h_padding=\u00bb0&#8243; top_padding=\u00bb0&#8243; bottom_padding=\u00bb0&#8243; overlay_alpha=\u00bb50&#8243; equal_height=\u00bbyes\u00bb gutter_size=\u00bb0&#8243; column_width_percent=\u00bb100&#8243; shift_y=\u00bb0&#8243; z_index=\u00bb0&#8243; css=\u00bb.vc_custom_1617432177872{margin-top: 70px !important;}\u00bb el_class=\u00bbdestructor-total mg-iclos-right\u00bb][vc_column column_width_percent=\u00bb100&#8243; position_vertical=\u00bbbottom\u00bb gutter_size=\u00bb0&#8243; back_image=\u00bb85267&#8243; overlay_alpha=\u00bb50&#8243; shift_x=\u00bb0&#8243; shift_y=\u00bb0&#8243; shift_y_down=\u00bb0&#8243; z_index=\u00bb0&#8243; medium_width=\u00bb0&#8243; mobile_width=\u00bb0&#8243; width=\u00bb1\/2&#8243; mobile_height=\u00bb200&#8243;][vc_row_inner row_inner_height_percent=\u00bb0&#8243; overlay_alpha=\u00bb50&#8243; gutter_size=\u00bb3&#8243; shift_y=\u00bb0&#8243; z_index=\u00bb0&#8243; el_id=\u00bbmodelo-box-azul\u00bb][vc_column_inner column_width_percent=\u00bb100&#8243; position_vertical=\u00bbbottom\u00bb gutter_size=\u00bb0&#8243; overlay_alpha=\u00bb50&#8243; shift_x=\u00bb0&#8243; shift_y=\u00bb0&#8243; shift_y_down=\u00bb0&#8243; z_index=\u00bb0&#8243; medium_width=\u00bb0&#8243; mobile_width=\u00bb0&#8243; width=\u00bb1\/1&#8243; el_class=\u00bbpg-iclos\u00bb][vc_custom_heading heading_semantic=\u00bbh3&#8243; text_font=\u00bbfont-195522&#8243; text_size=\u00bbh1&#8243; text_weight=\u00bb700&#8243; text_color=\u00bbcolor-xsdn\u00bb]We Produce for the World:[\/vc_custom_heading][vc_custom_heading heading_semantic=\u00bbh3&#8243; text_font=\u00bbfont-195522&#8243; text_size=\u00bbh1&#8243; text_weight=\u00bb400&#8243; text_color=\u00bbcolor-xsdn\u00bb]<\/p>\n<ul>\n<li>Active ingredients of biotechnology products<\/li>\n<li>Finished products<\/li>\n<\/ul>\n<p>[\/vc_custom_heading][\/vc_column_inner][\/vc_row_inner][\/vc_column][vc_column column_width_percent=\u00bb100&#8243; gutter_size=\u00bb0&#8243; overlay_alpha=\u00bb50&#8243; shift_x=\u00bb0&#8243; shift_y=\u00bb0&#8243; shift_y_down=\u00bb0&#8243; z_index=\u00bb0&#8243; medium_width=\u00bb0&#8243; mobile_width=\u00bb0&#8243; width=\u00bb1\/2&#8243; el_class=\u00bbpg-iclos\u00bb][vc_row_inner row_inner_height_percent=\u00bb0&#8243; overlay_alpha=\u00bb50&#8243; gutter_size=\u00bb3&#8243; shift_y=\u00bb0&#8243; z_index=\u00bb0&#8243; limit_content=\u00bb\u00bb][vc_column_inner column_width_percent=\u00bb100&#8243; gutter_size=\u00bb3&#8243; override_padding=\u00bbyes\u00bb column_padding=\u00bb4&#8243; overlay_alpha=\u00bb50&#8243; shift_x=\u00bb0&#8243; shift_y=\u00bb0&#8243; shift_y_down=\u00bb0&#8243; z_index=\u00bb0&#8243; medium_width=\u00bb0&#8243; mobile_width=\u00bb0&#8243; width=\u00bb1\/1&#8243;][vc_custom_heading heading_semantic=\u00bbh3&#8243; text_font=\u00bbfont-195522&#8243; text_size=\u00bbh1&#8243; text_weight=\u00bb700&#8243; text_color=\u00bbcolor-459661&#8243; separator=\u00bbyes\u00bb separator_color=\u00bbyes\u00bb]Services to Third Parties[\/vc_custom_heading][vc_column_text text_lead=\u00bbyes\u00bb]We have strategic alliances with companies that demand quality manufacturing for the products they are developing. We are known for our culture of service to third parties, providing services as CMO (Contract Manufacturer Organization) and strengthening partnerships with major international companies. This allows us to offer our regulatory, logistics and commercial platform for the distribution and marketing of highly qualified products in Latin America.[\/vc_column_text][vc_button border_width=\u00bb0&#8243; el_class=\u00bbboton-iclos\u00bb el_id=\u00bbboton-iclos\u00bb link=\u00bburl:https%3A%2F%2Ficlos.global%2Feng%2Fcontact%2F|title:Contact\u00bb]CONTACT US[\/vc_button][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row unlock_row_content=\u00bbyes\u00bb row_height_percent=\u00bb1&#8243; override_padding=\u00bbyes\u00bb h_padding=\u00bb0&#8243; top_padding=\u00bb0&#8243; bottom_padding=\u00bb0&#8243; back_color=\u00bbcolor-877404&#8243; back_image=\u00bb84490&#8243; back_repeat=\u00bbrepeat-y\u00bb back_position=\u00bbcenter center\u00bb overlay_alpha=\u00bb50&#8243; equal_height=\u00bbyes\u00bb gutter_size=\u00bb0&#8243; column_width_percent=\u00bb0&#8243; shift_y=\u00bb0&#8243; z_index=\u00bb0&#8243; medium_visibility=\u00bbyes\u00bb mobile_visibility=\u00bbyes\u00bb [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-85188","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Business Model - ICLOS<\/title>\n<meta name=\"description\" content=\"En Megalabs trabajamos comprometidos con nuestras comunidades de Latinoam\u00e9rica para que m\u00e1s personas puedan acceder a medicamentos de calidad superior.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/iclos.global\/eng\/business-model\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Business Model - ICLOS\" \/>\n<meta property=\"og:description\" content=\"En Megalabs trabajamos comprometidos con nuestras comunidades de Latinoam\u00e9rica para que m\u00e1s personas puedan acceder a medicamentos de calidad superior.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/iclos.global\/eng\/business-model\/\" \/>\n<meta property=\"og:site_name\" content=\"ICLOS\" \/>\n<meta property=\"article:modified_time\" content=\"2021-06-03T06:13:27+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/iclos.global\/eng\/business-model\/\",\"url\":\"https:\/\/iclos.global\/eng\/business-model\/\",\"name\":\"Business Model - ICLOS\",\"isPartOf\":{\"@id\":\"https:\/\/iclos.global\/eng\/#website\"},\"datePublished\":\"2021-03-25T05:48:35+00:00\",\"dateModified\":\"2021-06-03T06:13:27+00:00\",\"description\":\"En Megalabs trabajamos comprometidos con nuestras comunidades de Latinoam\u00e9rica para que m\u00e1s personas puedan acceder a medicamentos de calidad superior.\",\"breadcrumb\":{\"@id\":\"https:\/\/iclos.global\/eng\/business-model\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/iclos.global\/eng\/business-model\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/iclos.global\/eng\/business-model\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/iclos.global\/eng\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Business Model\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/iclos.global\/eng\/#website\",\"url\":\"https:\/\/iclos.global\/eng\/\",\"name\":\"MEGALABS\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/iclos.global\/eng\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Business Model - ICLOS","description":"En Megalabs trabajamos comprometidos con nuestras comunidades de Latinoam\u00e9rica para que m\u00e1s personas puedan acceder a medicamentos de calidad superior.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/iclos.global\/eng\/business-model\/","og_locale":"es_ES","og_type":"article","og_title":"Business Model - ICLOS","og_description":"En Megalabs trabajamos comprometidos con nuestras comunidades de Latinoam\u00e9rica para que m\u00e1s personas puedan acceder a medicamentos de calidad superior.","og_url":"https:\/\/iclos.global\/eng\/business-model\/","og_site_name":"ICLOS","article_modified_time":"2021-06-03T06:13:27+00:00","twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/iclos.global\/eng\/business-model\/","url":"https:\/\/iclos.global\/eng\/business-model\/","name":"Business Model - ICLOS","isPartOf":{"@id":"https:\/\/iclos.global\/eng\/#website"},"datePublished":"2021-03-25T05:48:35+00:00","dateModified":"2021-06-03T06:13:27+00:00","description":"En Megalabs trabajamos comprometidos con nuestras comunidades de Latinoam\u00e9rica para que m\u00e1s personas puedan acceder a medicamentos de calidad superior.","breadcrumb":{"@id":"https:\/\/iclos.global\/eng\/business-model\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/iclos.global\/eng\/business-model\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/iclos.global\/eng\/business-model\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/iclos.global\/eng\/"},{"@type":"ListItem","position":2,"name":"Business Model"}]},{"@type":"WebSite","@id":"https:\/\/iclos.global\/eng\/#website","url":"https:\/\/iclos.global\/eng\/","name":"MEGALABS","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/iclos.global\/eng\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"}]}},"_links":{"self":[{"href":"https:\/\/iclos.global\/eng\/wp-json\/wp\/v2\/pages\/85188","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/iclos.global\/eng\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/iclos.global\/eng\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/iclos.global\/eng\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/iclos.global\/eng\/wp-json\/wp\/v2\/comments?post=85188"}],"version-history":[{"count":0,"href":"https:\/\/iclos.global\/eng\/wp-json\/wp\/v2\/pages\/85188\/revisions"}],"wp:attachment":[{"href":"https:\/\/iclos.global\/eng\/wp-json\/wp\/v2\/media?parent=85188"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}